Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 5Recruiting 5Withdrawn 4Active not recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1

Conditions

Locally Advanced Rectal Cancer 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 225Cyclophosphamide 194Radiotherapy 181Nivolumab 181Carboplatin 155Paclitaxel 114Cisplatin 113Dexamethasone 111Radiosurgery 103Magnetic Resonance Spectroscopy 98Surveys and Questionnaires 92Ipilimumab 82Doxorubicin 80Lenalidomide 77durvalumab 76Rituximab 75atezolizumab 73Radiation 72venetoclax 69Standard of Care 69fludarabine 68Gemcitabine 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Docetaxel 60Oxaliplatin 59Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Thymalfasin × Clear all
NCT06139419 2025-11-17

The Impact of Thymosin α-1 on the Efficacy of Concurrent Chemoradiotherapy Followed by Immunotherpay Consolidation for Locally Advanced NSCLC

Sun Yat-sen University

Phase 2 Active not recruiting
114 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06056804 2025-04-02

Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and Thymalfasin for pMMR/MSS Locally Advanced Mid-low Rectal Cancer

Beijing Friendship Hospital

Phase 2 Active not recruiting
20 enrolled
Gastrointestinal

Locally Advanced Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡